[Immunotherapy in rheumatoid arthritis; current status].
Breedveld
F C
FC
Academisch Ziekenhuis, afd. Reumatologie, Leiden.
van de Putte
L B
LB
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D015704:CD4 Antigens / Q000276:immunology; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008134:Long-Term Care; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha
Immuuntherapie bij reumatoïde artritis; huidige stand van zaken.